Publications by authors named "Vincent Gros"

Claim this Profile
V
Virus-Induced Cellular Senescence Causes Pulmonary Sequelae Post-Influenza Infection.
Larissa Lipskaia, Lou Delval, Valentin Sencio, Emmanuelle Born, Séverine Heumel, Vincent Gros

Aging Cell· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benidipine calcium channel blocker promotes the death of cigarette smoke-induced senescent cells and improves lung emphysema.
Alberta Palazzo, Gabriela Makulyte, Delphine Goerhig, Jean-Jacques Médard, Vincent Gros

Aging (Albany NY)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
Marc Humbert, Camille Taillé, Laurence Mala, Vincent Le Gros, Jocelyne Just

Eur Respir J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.
Pierre-Olivier Girodet, Jean-Yves Jasnot, Vincent Le Gros, Laurent Decuypère, Weihua Cao

Respir Med· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.
Pierre-Régis Burgel, Vincent Le Gros, Laurent Decuypère, Isabelle Bourdeix, Thierry Perez

BMC Pulm Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.
Gilles Garcia, Antoine Magnan, Raphaël Chiron, Cécile Contin-Bordes, Patrick Berger, Vincent Le Gros

Chest· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab-induced decrease of FcξRI expression in patients with severe allergic asthma.
Pascal Chanez, Cécile Contin-Bordes, Gilles Garcia, Christophe Verkindre, Alain Didier, Vincent Le Gros

Respir Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into severe asthma control as assessed by guidelines, pulmonologist, patient, and partner.
Mathieu Molimard, Daniel Vervloet, Vincent Le Gros, Isabelle Bourdeix, Anne Ponthieux

J Asthma· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and associated factors of oropharyngeal side effects in users of inhaled corticosteroids in a real-life setting.
Mathieu Molimard, Vincent Le Gros, Philip Robinson, Isabelle Bourdeix

J Aerosol Med Pulm Drug Deliv· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of patient-related factors on asthma control.
Mathieu Molimard, Vincent Le Gros

J Asthma· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of omalizumab (Xolair) in the first patients treated in real-life practice in France.
Mathieu Molimard, Frédéric de Blay, Alain Didier, Vincent Le Gros

Respir Med· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underdiagnosis of nocturnal symptoms in asthma in general practice.
Chantal Raherison, Abdel Abouelfath, Vincent Le Gros, André Taytard, Mathieu Molimard

J Asthma· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total reversibility testing as indicator of the clinical efficacy of formoterol in COPD.
Mathieu Molimard, Jacques Bourcereau, Vincent Le Gros, Isabelle Bourdeix

Respir Med· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of formoterol and salmeterol on resting inspiratory capacity in COPD patients with poor FEV(1) reversibility.
Demosthenes Bouros, John Kottakis, Vincent Le Gros, Tim Overend, Giovanni Della Cioppa

Curr Med Res Opin· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of omalizumab in health care workers with occupational latex allergy.
Francisque Leynadier, Ouafia Doudou, Hafida Gaouar, Vincent Le Gros, Isabelle Bourdeix

J Allergy Clin Immunol· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study.
Christian Brambilla, Vincent Le Gros, Isabelle Bourdeix,

Clin Ther· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faster onset of bronchodilation with formoterol than with salmeterol in patients with stable, moderate to severe COPD: results of a randomized, double-blind clinical study.
John Kottakis, Giovanni Della Cioppa, Jacques Creemers, Louis Greefhorst, Violette Lecler, Vincent Le Gros

Can Respir J· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis